WO2006076712A2 - Expandable osteoimplant - Google Patents
Expandable osteoimplant Download PDFInfo
- Publication number
- WO2006076712A2 WO2006076712A2 PCT/US2006/001540 US2006001540W WO2006076712A2 WO 2006076712 A2 WO2006076712 A2 WO 2006076712A2 US 2006001540 W US2006001540 W US 2006001540W WO 2006076712 A2 WO2006076712 A2 WO 2006076712A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- osteoimplant
- demineralized
- bone
- state
- expanded state
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2/4455—Joints for the spine, e.g. vertebrae, spinal discs for the fusion of spinal bodies, e.g. intervertebral fusion of adjacent spinal bodies, e.g. fusion cages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3608—Bone, e.g. demineralised bone matrix [DBM], bone powder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
- A61L27/3645—Connective tissue
- A61L27/365—Bones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/3094—Designing or manufacturing processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2/442—Intervertebral or spinal discs, e.g. resilient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
- A61F2002/2817—Bone stimulation by chemical reactions or by osteogenic or biological products for enhancing ossification, e.g. by bone morphogenetic or morphogenic proteins [BMP] or by transforming growth factors [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
- A61F2002/2835—Bone graft implants for filling a bony defect or an endoprosthesis cavity, e.g. by synthetic material or biological material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
- A61F2002/2835—Bone graft implants for filling a bony defect or an endoprosthesis cavity, e.g. by synthetic material or biological material
- A61F2002/2839—Bone plugs or bone graft dowels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/30004—Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis
- A61F2002/30057—Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis made from both cortical and cancellous adjacent parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/3006—Properties of materials and coating materials
- A61F2002/30062—(bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/3006—Properties of materials and coating materials
- A61F2002/30075—Properties of materials and coating materials swellable, e.g. when wetted
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30108—Shapes
- A61F2002/3011—Cross-sections or two-dimensional shapes
- A61F2002/30112—Rounded shapes, e.g. with rounded corners
- A61F2002/30131—Rounded shapes, e.g. with rounded corners horseshoe- or crescent- or C-shaped or U-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30108—Shapes
- A61F2002/3011—Cross-sections or two-dimensional shapes
- A61F2002/30138—Convex polygonal shapes
- A61F2002/30153—Convex polygonal shapes rectangular
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30108—Shapes
- A61F2002/30199—Three-dimensional shapes
- A61F2002/30224—Three-dimensional shapes cylindrical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30535—Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30563—Special structural features of bone or joint prostheses not otherwise provided for having elastic means or damping means, different from springs, e.g. including an elastomeric core or shock absorbers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30535—Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30579—Special structural features of bone or joint prostheses not otherwise provided for with mechanically expandable devices, e.g. fixation devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30535—Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30593—Special structural features of bone or joint prostheses not otherwise provided for hollow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30535—Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30599—Special structural features of bone or joint prostheses not otherwise provided for stackable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/3094—Designing or manufacturing processes
- A61F2/30942—Designing or manufacturing processes for designing or making customized prostheses, e.g. using templates, CT or NMR scans, finite-element analysis or CAD-CAM techniques
- A61F2002/30957—Designing or manufacturing processes for designing or making customized prostheses, e.g. using templates, CT or NMR scans, finite-element analysis or CAD-CAM techniques using a positive or a negative model, e.g. moulds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0061—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof swellable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
- A61F2230/0013—Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0017—Angular shapes
- A61F2230/0019—Angular shapes rectangular
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0069—Three-dimensional shapes cylindrical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/006—Additional features; Implant or prostheses properties not otherwise provided for modular
- A61F2250/0063—Nested prosthetic parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00179—Ceramics or ceramic-like structures
- A61F2310/00293—Ceramics or ceramic-like structures containing a phosphorus-containing compound, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00359—Bone or bony tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00365—Proteins; Polypeptides; Degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
Definitions
- This invention relates generally to an osteoimplant, and more specifically to an osteoimplant comprising an expandable, biocompatible material.
- the expandable material may include demineralized cancellous chips, demineralized cortical fibers, expandable polymers, other suitable materials, or combinations of these.
- the osteoimplant has a first state and an expanded state, and it may be used with another device or on its own.
- the invention also relates generally to a method for manufacturing the osteoimplant.
- Implants for such procedures take a wide variety of shapes, forms, and materials, from bone to titanium inert materials, rigid and elastic, circular cylindrical, wedge shapes, and cages with or without openings to accept bone fusion promoting material.
- the implants are dimensioned and shaped to fill a predetermined disc space between the adjacent vertebra to be fused.
- Bone grafts are commonly used in treating bone fractures and defects.
- bone grafts may be used as part of spinal surgery to encourage bone fusion with or through the implant.
- Bone grafting procedures are directed to a diverse array of medical interventions for complications such as fractures involving bone loss, injuries, or other conditions necessitating immobilization by fusion (such as for the spine or joints), and other bone defects that may be present due to trauma, infection, or disease.
- Bone grafting involves the surgical transplantation of pieces of bone within the body, and generally is effectuated through the use of graft material acquired from a human source.
- Orthopedic autografts or autogenous grafts involve source bone acquired from the individual receiving the transplantation.
- this type of transplant moves bony material from one location in a body to another location in the same body, and has the advantage of producing minimal immunological complications.
- the grafts may be placed, for example, in a host bone and serve as the substructure for supporting new bone tissue growth from the host bone.
- the grafts are sculpted to assume a shape that is appropriate for insertion at the fracture or defect area, and often require fixation to that area as by screws or pins.
- an osteoimplant and a method for manufacturing the osteoimplant are provided. More specifically, an osteoimplant comprising demineralized bone particles has a first state and an expanded state. The osteoimplant may be used with another device or on its own.
- the osteoimplant may be inserted into a device such as an intervertebral body fusion device.
- the osteoimplant may alternatively be referred to as a bone insert.
- the osteoimplant may be rehydrated to expand to an increased size, for example as far as permitted by the confines of the intervertebral body fusion device and spinal endplates, thereby aiding in greater vertebral endplate contact and conformity in spinal surgery.
- the osteoimplant may be used on its own, for example in a surgical opening or anatomical void, where it is desirable that the osteoimplant expand from a first state to an expanded state.
- Figure 1 illustrates an osteoimplant in accordance with one embodiment of the present invention.
- Figure 2 illustrates an intervertebral fusion device for receipt of an osteoimplant in accordance with one embodiment of the present invention.
- Figure 3 a illustrates one embodiment of the osteoimplant of the present invention that has been inserted into the intervertebral fusion device of Figure 2 and is in a first state.
- Figure 3b illustrates one embodiment of the osteoimplant of the present invention that has been inserted into the intervertebral fusion device of Figure 2 and is in an expanded state.
- Figure 4 illustrates an intervertebral device spaced between substantially uniform vertebral endplates.
- Figure 5 illustrates an intervertebral device spaced between non-uniform vertebral endplates.
- Figure 6 illustrates the intervertebral device of Figure 5 after expansion.
- Figure 7 illustrates an intervertebral device with the osteoimplant in accordance with one embodiment of the present invention and illustrates the expansion of the osteoimplant and the bone growth present at the site at approximately 4 weeks.
- Figure 8 illustrates an osteoimplant after 0 minutes rehydration.
- Figure 9 illustrates an osteoimplant after 30 minutes rehydration.
- Figure 10 illustrates Insertion/Expansion testing of an osteoimplant in accordance with one embodiment of the present invention.
- Figure 11 illustrates Insertion/Expansion testing of an osteoimplant in accordance with one embodiment of the present invention.
- Figure 12 illustrates Insertion/Expansion testing of an osteoimplant in accordance with one embodiment of the present invention.
- Figure 13 illustrates sample expansion of an osteoimplant in a vertebral cage in accordance with one embodiment of the present invention.
- osteoimplant herein is utilized in its broadest sense and is not intended to be limited to any particular material, shapes, sizes, configurations, or applications. It may include any material, such as allograft, xenograft, or synthetic material, used to promote or support bone healing.
- shape refers to a determined or regular form or configuration, in contrast to an indeterminate or vague form or configuration (as in the case of a lump or other solid mass of no special form), and is characteristic of such materials as sheets, plates, disks, cones, pins, screws, tubes, teeth, bones, portion of bone, wedges, cylinders, threaded cylinders, and the like.
- osteoogenic refers to the ability of a substance to induce new bone formation via the participation of living cells from within the substance. Stated otherwise, the term osteogenic shall be understood as referring to the ability of the osteoimplant to enhance or accelerate the ingrowth of new bone tissue by one or more mechanisms such as osteogenesis, osteoconduction, and/or osteoinduction.
- osteoconductive refers to the ability of a substance or material to provide biologically inert surfaces that are receptive to the growth of new host bone.
- osteoinductive shall be understood to refer to the ability of a substance to recruit cells from the host that have the potential for repairing bone tissue.
- osteoconformingTM refers to the ability of a substance conform to biological geometries in vivo.
- bone-derived elements refers to pieces of bone in any variety of sizes, thicknesses, and configurations, including particles, fibers, strips, thin to thick sheets, etc., which can be obtained by milling, slicing, cutting, or machining whole bone.
- bone particles refers to pieces of bone and may comprise cancellous bone pieces, cortical bone pieces, or a combination thereof.
- the bone particles may be partially or fully demineralized and/or combined with nondemineralized bone particles and/or other materials.
- the bone particles may be obtained from cortical, cancellous, and/or corticocancellous bone that may be of autogenous, allogenic, and/or xenogenic origin.
- the bone particles may be powdered bone particles possessing a wide range of particle sizes ranging from relatively fine powders to coarse grains and even larger chips.
- the bone particles may range in size from approximately 1 mm to approximately 15 mm.
- the pieces of bone may alternatively be elongate, possessing relatively high median length to median thickness ratios may be utilized herein.
- Such elongate particles may be referred to as fibers.
- the elongate bone particles may have a median length of from about 2 to about 200 mm, a median thickness of from about 0.05 to about 2 mm, and a median width of from about 1 mm to about 20 mm.
- incorporación refers to the biological mechanism whereby host tissue gradually removes portions of the osteoimplant of the invention and replaces those removed portions with native host bone tissue while maintaining strength. This phenomenon also is known in the scientific literature as “creeping substitution.”
- incorporación utilized herein shall be understood as embracing what is known by those skilled in the art as “creeping substitution.”
- Demineralized refers to removal of minerals from bone. Demineralization may range from substantially complete (in which case the bone-derived elements are primarily collagen) to partial or superficial (in which case only the surfaces of the bone- derived elements present exposed collagen). Partial or superficial demineralization produces bone-derived elements having a surface binding region, namely, exposed collagen, while retaining a strengthening region, namely, the unaffected nondemineralized region of the bone-derived elements.
- surface- exposed collagen refers to the result obtained by demineralizing bone-derived elements.
- Biocompatible material refers to a material not having toxic or injurious effects on biological function that would be inappropriate in a specific application.
- Bioactive agent refers to a compound or entity that alters, inhibits, activates, or otherwise affects biological or chemical events.
- bioactive agents may include, but are not limited to, osteogenic or chondrogenic proteins or peptides, anti-AIDS substances, anti-cancer substances, antibiotics, immunosuppressants, anti-viral substances, enzyme inhibitors, hormones, neurotoxins, opioids, hypnotics, anti-histamines, lubricants, tranquilizers, anticonvulsants, muscle relaxants and anti-Parkinson substances, anti-spasmodics and muscle contractants including channel blockers, miotics and anti-cholinergics, anti- glaucoma compounds, anti-parasite and/or anti-protozoal compounds, modulators of cell-extracellular matrix interactions including cell growth inhibitors and antiadhesion molecules, vasodilating agents, inhibitors of DNA, RNA or protein synthesis, antihypertensives, analgesics,
- the bioactive agent is a drug.
- the bioactive agent is a growth factor, cytokine, extracellular matrix molecule or a fragment or derivative thereof, for example, a cell attachment sequence such as RGD.
- RGD cell attachment sequence
- An osteoimplant and a method for manufacturing the osteoimplant are provided. More specifically, a shaped osteoimplant comprising an expandable material has a first state and an expanded state that may be used with another device or on its own, and a method for manufacturing such implant, are provided.
- the expandable material may comprise demineralized bone particles such as demineralized cancellous chips, demineralized cortical fibers, a synthetic material such as a polymer, any other suitable material, or combinations thereof.
- the osteoimplant may alternatively be referred to as a bone insert.
- Figure 1 illustrates an osteoimplant 10 in accordance with one embodiment.
- the osteoimplant 10 is a shaped implant designed for expansion in vivo.
- the osteoimplant expands to the contours of the vertebral endplates, creating a matrix for cellular penetration to promote bone healing.
- the osteoimplant comprises an expandable material.
- the expandable material may be natural or synthetic.
- the expandable material may comprise bone particles, a polymer, a hydrogel, a sponge, collagen, or other material.
- the osteoimplant comprises bone allograft comprising demineralized bone particles.
- the demineralized bone particles may be a blend of cortical and cancellous bone.
- the osteoimplant may comprise demineralized cortical fibers and demineralized cancellous chips. Inductive cortical fibers are demineralized to expose naturally occurring growth factors found in bone. Demineralized cancellous chips create a healthy matrix for the incorporation of new bone and add advanced expansion characteristics.
- the osteoimplant may comprise, in whole or part, a synthetic material.
- an expandable polymer in addition to bone particles, an expandable polymer, a collagen sponge, compressed and/or dried hydrogels, or other materials may be used.
- the material may exhibit osteoinductive and/or osteoconductive properties.
- cancellous bone particles may exhibit osteoconductive properties while demineralized cortical bone particles may exhibit osteoinductive properties.
- Expansion properties may be imparted to the osteoimplant in any suitable manner.
- expansion properties may be affected by the materials used to form the osteoimplant and/or by the manner used to form the osteoimplant.
- the osteoimplant may be configured to expand at least 10 percent, or from approximately 10 percent to approximately 1000 percent.
- the material used to form the implant may be selected based on the amount of expansion desired.
- the material may include coiled fibers, or it may be compressed, spring-loaded, or otherwise configured for expansion.
- Compressing the material during formation may lead to subsequent expansion.
- increased compression leads to increased expansion characteristics in the osteoimplant.
- Compressed materials and certain noncompressed materials may be constrained such that, absent the constraint, the material is free to expand.
- a constrained material is one that embodies energy, such as a bent, spring- loaded, or coiled material, or any other material that is artificially prevented from expanding or conforming to its natural configuration.
- the constraint may comprise a membrane that partially or wholly surrounds the material.
- the membrane may be provided around the material such that removal of the membrane permits the material to expand from its first state.
- the membrane may be a protective barrier such that removal of the membrane exposes the material to conditions that may activate expansion.
- Such membrane may be configured, for example, as a layer that disintegrates in vivo.
- the membrane may be a biocompatible, biodegradable material such as a polyester based on polylactide (PLA), polyglycolide (PGA), polycaprolactone (PCL), and their copolymers, or it may be any other suitable material.
- the membrane may be a protective material or restraining barrier that is removed prior to implantation of the osteoimplant.
- Expansion may be activated in any suitable manner.
- expansion may be activated by exposure to air, water, blood, heat, removal of a constraint, or otherwise.
- the osteoimplant may be compressed and dried. Upon exposure to liquid in vivo, the osteoimplant expands.
- the osteoimplant may be compressed and constrained by a membrane. Upon exposure to liquid in vivo, the membrane disintegrates, and the osteoimplant expands.
- the osteoimplant may be constrained by a protective material or restraining barrier. Upon removal of the material or barrier, the material expands as a function of time.
- the osteoimplant has a first state at approximately 60 degrees F and an expanded state at approximately 98 degrees F such that, upon implantation in vivo and exposure to body heat, the osteoimplant expands.
- the osteoimplant is vacuum-sealed upon formation and packaging and, when unsealed and exposed to air, expands.
- the direction of expansion may be controlled or uncontrolled.
- the osteoimplant may be constrained in directions other than the desired direction of expansion.
- the osteoimplant may be compressed only in the direction of desired expansion.
- the osteoimplant may expand in any or all desired directions.
- the osteoimplant may be configured to be load-bearing, may be configured for insertion into a load-bearing implant, or may be used in a non-load-bearing capacity.
- the osteoimplant may be shaped. Such shaping may comprise compressing the material in a mold and drying under compression. Drying may be done via freeze-drying, solvent drying, or heat-drying.
- the resulting osteoimplant is expansive.
- the resulting osteoimplant may be configured for expansion of approximately 2 to 10 mm upon rehydration.
- the osteoimplant may be left unshaped and be used to fill a space in another implant or in a bone defect.
- the osteoimplant exhibits osteoconformingTM characteristics.
- the osteoimplant expands upon rehydration in-vivo to conform to, for example, adjacent vertebral bodies. This maximizes the surface area contact between the graft and the endplate for optimal interface and cellular exchange.
- the osteoimplant may further exhibit osteoinductive and osteoconductive characteristics. Materials used to manufacture the osteoimplant may be chosen with deference to these characteristics. For example, in an osteoimplant comprising demineralized bone particles, demineralized cortical fibers provide osteoinductive characteristics, while demineralized cancellous chips provide osteoconductive characteristics and enhanced expansion.
- the cortical fibers contribute to the bone formation process while the cancellous chips provide optimal scaffold for vascularization and bone formation, thereby providing a healthy matrix for the new bone growth.
- Bone particles and/or other materials may be employed.
- one or more types of demineralized bone particles, cancellous or cortical, or expandable material may be employed in combination with nondemineralized bone particles, i.e., bone particles that have not been subjected to a demineralization process, or other materials.
- the exact composition of the implant for example, the extent of demineralization of bone particles and the ratio of demineralized bone particles, nondemineralized bone particles, synthetic materials, and other materials may vary depending on the desired use of the osteoimplant. For example, osteoimplants that are to be used as an intervertebral fusion device may be provided with enhanced strength.
- the osteoinductivity of the osteoimplant and/or providing a coherency or binding effect may be of greater importance, in which case a greater fraction of fully demineralized bone particles may be used.
- the strength of the osteoimplant may take on greater importance, and superficially or partially demineralized bone particles and/or nondemineralized bone particles may be used in the osteoimplant.
- the osteoimplant may optionally include additional biocompatible component(s) such as wetting agents, biocompatible binders, fillers, fibers, plasticizers, biostatic/biocidal agents, surface active agents, bioactive agents, and the like. Carriers also may be used where appropriate.
- the osteoimplant may optionally possess one or more other components such as reinforcing particles, fibers, fillers, bone-growth inducing substances such as growth factors, adhesives, plasticizers, flexibilizing agents, hydration facilitating agents, biostatic/biocidal agents, analgesics, hemostats, substances imparting radiopacity such as nondemineralized bone chips, metallic meshes, structural pins and screws, and the like.
- reinforcing particles include nondemineralized cortical and cancellous bone, and partially demineralized cortical and cancellous bone in any form, including particles, sheets, and shaped bone particles, as well as graphite or pyrolytic carbon or any other suitable material.
- fillers include mineral material such as hydroxyapatite, tricalcium phosphate and other calcium salts, bone powder, fully nondemineralized and partially or fully demineralized cortical and cancellous bone in any form, including particles such as demineralized bone powder, sheets, and shaped bone particles, graphite or pyrolytic carbon, bioglass or other bioceramic or natural or synthetic polymers, e.g., bioabsorbable polymers such as polyglycolide, polylactide, glycolide-lactide copolymer, and the like, and nonbioabsorbable materials such as starches, polymethyl methacrylate, polytetrafiuoroethylene, polyurethane, polyethylene, and nylon, other suitable materials, or any combination of these.
- mineral material such as hydroxyapatite, tricalcium phosphate and other calcium salts
- bone powder fully nondemineralized and partially or fully demineralized cortical and cancellous bone in any form, including particles such as demineralized
- Suitable plasticizers, flexibilizing agents and hydration facilitating agents include liquid polyhydroxy compounds such as glycerol, monacetin, diacetin, and mixtures thereof.
- Suitable biostatic/biocidal agents include antibiotics, povidone, sugars, and mixtures thereof;
- suitable surface agents include the biocompatible nonionic, cationic, anionic and amphoteric surfactants, and mixtures thereof.
- Suitable bioactive agents include any compound or entity that alters, inhibits, activates, or otherwise affects biological or chemical events.
- bioactive agents may include, but are not limited to, osteogenic or chondrogenic proteins or peptides, anti-AIDS substances, anti-cancer substances, antibiotics, immunosuppressants, anti-viral substances, enzyme inhibitors, hormones, neurotoxins, opioids, hypnotics, anti-histamines, lubricants, tranquilizers, anti-convulsants, muscle relaxants and anti-Parkinson substances, anti-spasmodics and muscle contractants including channel blockers, miotics and anti-cholinergics, anti- glaucoma compounds, anti-parasite and/or anti-protozoal compounds, modulators of cell-extracellular matrix interactions including cell growth inhibitors and antiadhesion molecules, vasodilating agents, inhibitors of DNA, RNA or protein synthesis, antihypertensives, analgesics, anti-pyretics, steroidal and non-steroidal anti-inflammatory agents, anti-angiogenic factors, angiogenic factors, anti-secretory factors, anticoagul
- Additional components such as described above may be added in any suitable manner. Liquids may inhibit expansion. Accordingly, for components that are added in liquid form, it may be desirable to solidify the liquid in the osteoimplant.
- the osteoimplant may be configured for insertion into another implant, such as a vertebral cage.
- the osteoimplant may be used by itself, for example in a surgical opening or anatomical void, where it is desirable that the osteoimplant expand from a first state to an expanded state.
- the osteoimplant may absorb blood, and thus may exhibit hemostatic properties, in which case the osteoimplant may be used as a plug.
- the osteoimplant may be molded into any suitable shape.
- the osteoimplant may be fashioned into a variety of shapes and sizes which are not limited by constraints imposed by, for example, size and/or types of donor bone which are available for construction of the osteoimplant.
- Example shapes include rectangles, squares, horseshoes, matchsticks, cylinders, beads, pellets, gum-like strips, etc.
- shapes such as squares and rectangles are useful in interbody fusion, whether cervical, thoracic, or lumbar, as they efficiently deliver a large volume of implant material and are stackable.
- Shapes such as matchsticks may be useful for minimally invasive procedures, such as in delivery to an interbody fusion site.
- Filled cylinders may be used as a seat for a screw or other piece of hardware, or to provide a plug for a burr hole.
- Rings and cups may be used to deliver cages or other interbody fusion devices. Based on the degree of compression (thus, on the amount of material and the size of the mold) and, for bone, the degree of demineralization, the desired degree of porosity of the osteoimplant may be achieved.
- the osteoimplants are provided as 5 mm by 20 mm blocks in three heights: 8 mm, 12 mm, and 16 mm.
- the osteoimplant may function as a carrier for, and effectively diffuse, one or more bone-growth inducing substances that promote new bone growth and/or accelerate healing.
- the osteoimplant may be used with a carrier device such as an intervertebral fusion device, or it may be used on its own.
- the osteoimplant 10 may be configured as an insert that conforms to a graft chamber of a particular device 12 such as a structural spinal device.
- the osteoimplant may be used with a graft chamber including a through opening in the superior-inferior direction.
- the osteoimplant expands within the graft chamber, the expansion being confined by the graft chamber and the vertebral endplates.
- the osteoimplant makes full contact with the endplates, regardless of whether the endplates are uneven or concave. The osteoimplant thereby increases the potential for successful interbody fusion.
- the osteoimplant By confining the osteoimplant in one direction, for example with a cage, the osteoimplant is forced to expand in another direction.
- the direction of expansion may be controlled as desired for various procedures.
- Figure 2 illustrates an intervertebral fusion device 12 for receipt of an osteoimplant 10 in accordance with one embodiment of the present invention.
- Figure 3 a illustrates an osteoimplant 10 inserted into the intervertebral fusion device 12 of Figure 2 in the first state.
- Figure 3b illustrates an osteoimplant 10 inserted into the intervertebral fusion device 12 of Figure 2 in an expanded state.
- the depicted intervertebral fusion device 12 is merely an example of one such device that may be used, and is not intended to be limiting.
- the osteoimplant may be designed and configured to be received into any suitable implant device.
- the osteoimplant may be inserted into the intervertebral body fusion device in its first state.
- the osteoimplant may be configured in shape and size to generally correspond to the interior dimensions of the intervertebral body fusion device.
- the osteoimplant may be cut and/or manipulated to fit into a device.
- the osteoimplant may be rehydrated to expand to an increased size via, for example, addition of saline, the patient's own blood, bone marrow aspirate, or water.
- the amount of expansion may be preset.
- the osteoimplant may be configured to expand as far as permitted by the confines of the intervertebral body fusion device and the spinal endplates, thereby aiding in greater vertebral endplate contact and conformity in spinal surgery.
- the osteoimplant may be used with any suitable device for implantation in the body, such as where that device has an internal chamber.
- the osteoimplant is thus configured to generally correspond to the dimensions of the internal chamber.
- Such device may be formed of any suitable material.
- Example materials include, but are not limited to, metal (such as titanium), polymer, plastic, resorbable material, or bone such as allograft or autograft bone.
- such device may be any shape and the osteoimplant may be configured via use of a suitable mold for mating with any shape.
- the device may be circular, cylindrical, wedge shaped, or shaped as a cage (with or without openings).
- Figures 4-7 illustrate 'an osteoimplant used with an intervertebral device.
- FIG 4 illustrates an osteoimplant 10 within an intervertebral device 12 spaced between substantially uniform vertebral endplates 14.
- Figures 5 and 6 illustrate an osteoimplant 10 within an intervertebral device 12 spaced between non-uniform vertebral endplates 16.
- the osteoimplant 10 exhibits osteoconformingTM characteristics, expanding to contact the endplates 16.
- the osteoimplant thereby increases the potential for successful interbody fusion.
- the intervertebral device provides structural support while the osteoimplant provides osteoinduction and osteoconduction characteristics. Thus, all four of the contributing factors are met by an intervertebral device used with the osteoimplant of the present invention.
- Figure 7 illustrates the size of one embodiment of the implant in its first state
- the size of the implant as expanded in vivo 22 and the new bone growth 24 at the site at four weeks. As shown, there initially is an approximately 4 mm gap between the implant in its first state 20 and the adjacent vertebral endplate 26. This gap is filled in vivo via expansion of the osteoimplant. Bone growth 24 at the site at approximately four weeks is substantially equal at the top and the bottom of the implant.
- the osteoimplant may be produced using molds.
- the configuration of the osteoimplant may be controlled via the configuration of the mold.
- the shape of the mold may be configured to correspond to a cavity in which the osteoimplant will be fit.
- the osteoimplant may be approximately 0 to 0.5 mm smaller in length and width than the cage cavity to receive the osteoimplant.
- molds are provided having cavity length and width dimensions approximately equal to those of the corresponding cage.
- the molds are prepared having cavity length and width dimensions that are approximately 110% of the corresponding cage cavity dimensions, in which case the cavities are oversized such that, upon shrinkage of most implants during their preparation, they will fall into the range of 0 to 0.5 mm smaller in length and width than the cage cavity.
- corners of the molds may have a greater radius than the radius of the internal , cavity of the cage to prevent binding that may interfere with implant insertion.
- the implant mold height may be approximately 112% of the desired implant height to allow for shrinkage.
- the osteoimplant comprises bone particles.
- the bone particles may comprise cancellous bone chips, cortical fibers, or a combination thereof.
- the bone particles may be partially or fully demineralized and/or combined with nondemineralized bone particles and/or other materials. While particular reference is made to bone particles of allograft origin, the bone particles employed in the preparation of the osteoimplant may be obtained from cortical, cancellous, and/or corticocancellous bone that may be of autogenous, allogenic, and/or xenogenic origin.
- Porcine and bovine bone are types of xenogenic bone tissue that may be used individually or in combination as sources for the bone particles.
- Particles may be formed by milling whole bone to produce fibers, chipping whole bone, cutting whole bone, fracturing whole bone in liquid nitrogen, or otherwise disintegrating the bone tissue. Particles may optionally be sieved to produce those of a specific size.
- the osteoimplant comprises demineralized cancellous bone particles, which optionally may be supplemented with cortical bone particles. While nondemineralized cancellous bone may function in some load bearing capacity in wet and dry conditions, demineralized cancellous bone acts like a sponge when it is wet and exhibits "memory" properties when dried and subsequently rehydrated.
- the bone particles may be powdered bone particles possessing a wide range of particle sizes ranging from relatively fine powders to coarse grains and even larger chips. Thus, for example, powdered bone particles may range in average particle size from about 0.05 to about 1.2 cm and preferably from about 0.1 to about 1 cm and possess an average median length to median thickness ratio of from about 1:1 to about 3:1. If desired, powdered bone particles may be graded into different sizes to reduce or eliminate any less desirable size(s) of particles that maybe present.
- bone particles generally characterized as elongate and possessing relatively high median length to median thickness ratios may be utilized herein.
- Such elongate particles are referred to as fibers and may readily be obtained by any one of several methods, e.g., by milling or shaving the surface of an entire bone or relatively large section of bone.
- a mass of elongate bone particles containing at least about 60 weight percent, at least about 70 weight percent, or at least about 80 weight percent of elongate bone particles possessing a median length of from about 2 to about 200 mm or from about 10 to about 100 mm, a median thickness of from about 0.05 to about 2 mm or from about 0.2 to about 1 mm, and a median width of from about 1 mm to about 20 mm or from about 2 to about 5 mm. While any length may be used, longer fibers generally may perform better at holding cancellous bone chips. Longer fibers also may enhance osteoconductivity.
- the elongate bone particles can possess a median length to median thickness ratio of at least about 50:1 up to about 500:1 or more, or from about 50:1 to about 100:1, and a median length to median width ratio of from about 10:1 and about 200:1, or from about 50:1 to about 100:1.
- Another procedure for obtaining elongate bone particles, particularly useful for pieces of bone of up to about 100 mm in length, is the bone processing mill described in U.S. Patent No. 5,607,269, herein incorporated by reference. Use of this bone mill results in the production of long, thin strips that quickly curl lengthwise to provide tubular-like, coiled bone particles.
- elongate bone particles may be graded into different sizes to reduce or eliminate any less desirable size particles that may be present.
- elongate bone particles can be described as filaments, fibers, threads, slender or narrow strips, etc.
- the bone particles may be remodeled and partially replaced by new host bone as incorporation of the osteoimplant progresses in vivo.
- the osteoimplant may comprise bone particles including demineralized bone particles, nondemineralized bone particles, and combinations thereof.
- the bone particles can be fully demineralized by removing substantially all of the inorganic mineral content of the bone particles, partially demineralized by removing a significant amount, but less than all, of the inorganic mineral content of the bone particles, or superficially demineralized by removing a minor amount of the inorganic mineral content of the bone particles.
- Demineralized bone particles induce new bone formation at the site of the demineralized bone and permit adjustment of the overall mechanical properties of the osteoimplant. While the bone particles may be at least partially demineralized, incomplete demineralization of the cancellous and/or of the cortical bone particles provides radiopacity for imaging.
- Nondemineralized bone particles possess an initial and ongoing mechanical role, and later a biological role, in the osteoimplant.
- Superficial or partial demineralization produces particles containing a nondemineralized core. Particles of this type can contribute to the strength of the osteoimplant, through their nondemineralized core. These particles also play a biological role in bringing about new bone ingrowth by the process known as osteoinduction.
- Full demineralization produces particles in which nearly all of the mineral content has been removed from the particles. Particles treated in this way may contribute to the osteoinductivity of the osteoimplant and provide a coherency or binding effect.
- the degree of demineralization can be controlled as a function of the duration of treatment (i.e., submersion time in demineralizing agent) and the strength of the treatment medium (i.e., dilute or strong acid).
- the degree of "sponginess" or resiliency may be selected to meet a particular clinical application.
- the nondemineralized particles contribute to mechanical strength by being of a substantial size.
- the nondemineralized bone particles may be bound together in such a manner as to prevent disintegration.
- the nondemineralized bone particles may be provided in a retaining structure or material.
- the nondemineralized bone particles may be presented in any suitable manner so as to enhance the osteoimplant's mechanical strength.
- the bone particles may be demineralized in accordance with known and conventional procedures in order to reduce their inorganic mineral content.
- Demineralization methods remove the inorganic mineral component of bone by employing acid solutions. Such methods are well known in the art. See, for example, Reddi et al., Proc. Nat. Acad. Sci. 69, pp. 1601-05 (1972), incorporated herein by reference.
- the strength of the acid solution, the shape of the bone particles, and the duration of the demineralization treatment will determine the extent of demineralization. Reference in this regard may be made to Lewandrowski et al., J Biomed Materials Res, 31, pp 365-372 (1996), also incorporated herein by reference.
- the bone particles are subjected to a defatting/disinfecting step, followed by an acid demineralization step.
- the defatting/disinfecting step the bone is placed in a solution.
- An example defatting/disinfectant solution is an aqueous solution of ethanol, the ethanol being a good solvent for lipids and the water being a good hydrophilic carrier to enable the solution to penetrate more deeply into the bone particles.
- the aqueous ethanol solution also disinfects the bone by killing vegetative microorganisms and viruses.
- At least about 10 to about 40 percent by weight of water should be present in the defatting disinfecting solution to produce optimal lipid removal and disinfection within the shortest period of time.
- One concentration range of the defatting solution is from about 60 to about 85 weight percent alcohol or about 70 weight percent alcohol.
- Acids that can be employed in this step include inorganic acids, such as hydrochloric acid, and organic acids, such as peracetic acid. After acid treatment, the demineralized bone particles are rinsed with sterile water to remove residual amounts of acid and thereby raise the pH.
- the wet demineralized bone particles may be immediately shaped into any desired configuration or stored under aseptic conditions, advantageously in a lyophilized state, for processing at a later time.
- the particles may be shaped into a desired configuration and sterilized using known methods.
- Nondemineralized bone particles may be used in combination with demineralized bone particles to provide additional strength to the osteoimplant.
- Nondemineralized bone particles act as a stiffener, providing strength to the osteoimplant and enhancing its ability to support load.
- Nondemineralized bone particles may be used having sufficient size or being bound together to prevent disintegration such that the nondemineralized bone particles may aid the osteoimplant to initially support load.
- Nondemineralized bone particles also play a biological role in bringing about new bone ingrowth by osteoconduction. Thus, these bone particles are gradually remodeled and replaced by new host bone as incorporation of the osteoimplant progresses over time. Nondemineralized bone particles, however, need not be included in the osteoimplant.
- the osteoimplant is formed as follows.
- a plurality of bone particles are provided.
- the bone particles may comprise demineralized cancellous bone chips, demineralized cortical fibers, or a combination thereof. Any suitable ratio of bone types may be used.
- each of the cancellous bone particles and the cortical bone fibers may be provided as approximately 1 to 100% of the osteoimplant.
- the osteoimplant may comprise about 50% by weight cancellous bone chips and about 50% by weight cortical bone fibers.
- the cancellous bone particles may range in size, for example up to approximately 1.2 cm. In one embodiment, the cancellous bone particles and the cortical bone particles each range from approximately 1 mm to approximately 10 mm.
- an osteoimplant comprising a substantial majority of cancellous bone chips exhibits good expansion properties but is fragile and may break during handling in the dry state.
- an osteoimplant comprising a substantial majority of cortical bone fibers exhibits reduced expansion properties, but increased osteoinductivity.
- Increased compression of the osteoimplant may lead to increased expansion characteristics in the osteoimplant.
- the osteoimplant may be configured to expand to approximately the precompression size. In one embodiment, compression ranges from approximately 2 mm to approximately 20 mm. Compression may be performed in any suitable manner. In one embodiment, the bone particles are compressed via application of pressure in the direction of desired expansion.
- the bone particles are compressed, molded together, and, optionally, dried.
- An osteoimplant substantially free of liquid will exhibit increased expansion characteristics.
- drying may be accomplished, for example, via lyophilization or freeze-drying.
- Molding may cause the bone particles to form a solid, compact shape of predetermined dimensions.
- the dimensions may correspond to the dimensions of the mold used.
- the shape may be sized such that it mates with another device, or with an implant or surgical opening.
- the mold may be shaped to conform with the interior of a intervertebral body fusion device into which the osteoimplant may be inserted.
- the osteoimplant may be rehydrated, for example using a physiological saline (water containing 0.9 g NaCl/100 ml water) or water, or the patient's own blood. During rehydration, the freeze-dried solid of the osteoimplant expands to a larger size. Due to the "memory" properties of demineralized cancellous bone, discussed above, the demineralized, cancellous bone particles may be molded into any suitable shape to fill correspondingly sized or shaped cavities, or in geometries that are used to expand and fill any given shape smaller than or equal to the expanded size of the osteoimplant.
- the degree of expansion from compression may be used to produce an implant, such as a demineralized cancellous body, with particular porosity.
- Swelling agents other than or in addition to physiological saline and/or water also may be used.
- the osteoimplant comprises a synthetic material, i.e., a material other than bone.
- the synthetic material can be any material suitable for use in the present invention.
- the synthetic material may be an expandable polymer.
- the material may be a compressed, dried hydrogel.
- the osteoimplant may comprise a pseudo-synthetic material such as a collagen or cellulose sponge, which may be cross-linked or otherwise processed.
- the osteoimplant may also comprise combinations of these materials, and may further comprise bone. Any suitable material may be used but should generally be expandable, biocompatible, and lack immunogenicity.
- the osteoimplant may comprise a chemically-cross- linked glycosaminoglycan (GAG) hydrogel such as taught by Kirker, et. al. "Glycosaminoglycan Hydrogel Films as Bio-Interactive Dressings for Wound Healing”; Biomaterials 23 (2002) 3661-71.
- GAG chemically-cross- linked glycosaminoglycan
- Such hydrogel may comprise hyaluronan, hyaluronic acid, chondroitin sulfate (CS), or glycosaminoglycan (GAG)
- GAG molecules may be chemically modified to tailor their physiochemical and mechanical properties while retaining their natural bio-compatibility, bio-degradability, and lack of immunogenicity.
- the osteoimplant may comprise any material, such as a polymer, that is expandable.
- suitable polymers include fluoropolymers, polyolefins, and other suitable polymers.
- Suitable fluoropolymers include homopolymers of polytetrafluoroethylene and copolymers of polytetrafluoroethylene in which the co-monomer is ethylene, chlorotrifluoroethylene, perfluoroalkoxytetrafluoroethylene, and fluorinated propylene.
- Suitable Polyolefins include polypropylene and polyethylene.
- polyethylene terephthalate, polystyrene, and ultra high molecular weight polyethylene also may be suitable expandable materials.
- the osteoimplant may comprise an elastic hydrogel such as described in L. Sefc et. al. "Development of Hydrogel Implants for Urinary Incontinence Treatment”; Biomaterials 23 (2002) 3711-3715.
- the material may exhibit osteoinductive and/or osteoconductive properties.
- synthetic materials and cancellous bone may exhibit osteoconductive properties, while demineralized cortical bone particles may exhibit osteoinductive properties.
- any of the osteoimplants described above may be treated to enhance osteoinductivity, as described in Bone Matrix Compositions and Methods, K. Benham et al., U.S. Patent Application No. 60/732,675, filed November 1, 2005, which is hereby incorporated by reference in its entirety.
- inserts were compressed to 4mm.
- Molds were placed in -70 freezer for one hour, and then freeze dried using a freeze mobile for 24 hours. Implants numbered piece 11-piece 16. Pieces 11, 12, and 13 were for a 7 mm implant. Pieces 14, 15, and 16 were for a 15 mm implant. [095] Testing:
- Figure 8 illustrates an osteoimplant after 0 minutes rehydration.
- Figure 9 illustrates an osteoimplant after 30 minutes rehydration.
- Piece 11
- Bone insert functional fit experiments were conducted to test for fit of the bone insert into various intervertebral fusion devices. The experiments looked at rehydrated bone and nonrehydrated bone.
- FIGs 10-12 illustrate Insertion/Expansion testing of an osteoimplant 30 in accordance with one embodiment of the present invention. As shown, the osteoimplant 30 is formed in Figure 10 and tested within a device 32 in Figures 11 and 12.
- Table I illustrates the results of studies evaluating the expansion characteristics of osteoimplants comprising 100% fibers versus osteoimplants comprising 100% chips.
- the chips ranges in size from 1.7 mm to 10 mm.
- the test implants were made using 10 mm compression.
- the osteoimplants comprising 100% fibers generally expanded about 2 mm.
- the osteoimplants comprising 100% chips generally expanded about 14 mm.
- the fibers expanded less than their compression while the chips expanded more than their compression.
- FIG. 13 illustrates sample expansion of an osteoimplant 40 in a vertebral cage 42. As shown, the chips and fibers tend not to extrude out of the cage windows. Equivalent expansion of the implants while they were inserted in cages was measured. The dry dimensions were measured before the implants were put in the cage. During hydration, as the implants expanded, material extended beyond the tops of the cages. Calipers were used to measure the total height of the implants, as they extended beyond both ends of the cages. The difference between the hydrated height and the dry height was the expansion.
- Table III lists compression and expansion for various implant types:
- Table IV lists expansion values for various example embodiments.
- a glycosaminoglycan hydrogel is prepared as described in: Kirker, et. al.
- Glycosaminoglycan Hydrogel Films as Bio-Interactive Dressings for Wound Healing; Biomaterials 23 (2002) 3661-3671.
- HA hyaluronan
- CS chondroitin sulfate glycosaminoglycan
- HA-ADH is synthesized: HA is dissolved in water at 5 mg/ml. 5 M equivalent of adipic dihydrazide (ADH) and 3 equivalent of l-Ethyl-3-[3- (dimethylamino)-propyl]carbodiimide (EDCI) are added in solid form, while maintaining the pH at 4.75 by the addition of 1.0 N HCL. The reaction is stopped by raising the pH of reaction mixture to 7.0, followed by exhaustive dialysis. The solution is then centrifuged, and the supernatant lyophilized.
- ADH adipic dihydrazide
- EDCI l-Ethyl-3-[3- (dimethylamino)-propyl]carbodiimide
- CS-ADH Chondroitin sulfate (CS) is dissolved in water at 25 mg/ml. 5 M equivalent of adipic dihydrazide (ADH) and 2 equivalent of l-Ethyl-3-[3- (dimethylamino)-propyl]carbodiimide (EDCI) are added in solid form, while maintaining the pH at 4.75 by the addition of 1.0 N HCL. The reaction is stopped by raising the pH of reaction mixture to 7.0, followed by exhaustive dialysis. The solution is then centrifuged, and the supernatant lyophilized.
- ADH adipic dihydrazide
- EDCI l-Ethyl-3-[3- (dimethylamino)-propyl]carbodiimide
- the GAG-ADH (either HA-ADH or CS-ADH) is dissolved in water (5 mg/ml for HA-ADH and 25 mg/ml for CS-ADH) to form Solution A.
- PEG-diald is dissolved in water at a concentration of 50 mg/ml to form Solution B.
- Volumes of Solutions A and B are added to a small polystyrene dish to give desired equivalents of aldehyde and hydrazide functionalities, and the solutions are mixed with gentle swirling.
- a hydrogel forms within 60 seconds at room temperature. The mixture is agitated gently on an orbital platform for an additional 24 hours at 25 degrees Celsius to obtain a solid, uniform hydrogel.
- the hydrogel is stored overnight to allow solvent evaporation and thus provide a flexible HA film, which swells when rehydrated in aqueous solutions.
- the HA-ADH films may be prepared using an aldehyde: ADH ratio of 1:1.
- the CS-ADH films may be prepared with a ratio of 1 :4.
- the hydrogel is solvent cast with water into cylindrical 90 mm diameter beakers to a depth of about 30 mm. After casting, the material is put in a 40 degree C oven until dry. Upon removal from the oven, the cast sheets are removed from the beakers and chopped into particles about 3 to 6 mm in size.
- the hydrogel particles are mixed with wet DBM fibers in a 50/50 volume ratio and put into implant molds. The molds are put in a 40 degree C oven until dry and then removed and packaged. Upon hydration (after implantation), the hydrogel particles expand and cause the entire implant to expand.
- a glycosaminoglycan hydrogel is prepared as described in Kirker, et. al.
- the hydrogel solution is mixed with DBM fibers (25/75 DBM/Hydrogel solution) to form a fiber-hydrogel slurry.
- DBM fibers 25/75 DBM/Hydrogel solution
- the fiber-hydrogel slurry is poured into implant molds then put in a 40 degree C oven until dry.
- the molds are oversized such that the dry product is of the desired size. After implantation, the hydrogel portion swells and causes the implant to expand to fill the defect space.
- a 2-hydroxyethyl methacrylate hydrogel supplemented with methacrylate acid is prepared as described in L. Sefc et. al. "Development of Hydrogel Implants for Urinary Incontinence Treatment”; Biomaterials 23 (2002) 3711-15.
- 2-Hydroxyethyl methacrylate (HEMA) is mixed with freshly distilled methacrylic acid.
- a solution of ammonium persulfate in water is added. This solution is injected into a silicone tube with a syringe and the second end of the tube is closed. The tube is immersed into a 5% solution of sodium pyrosulphite for 24 hours.
- both ends of the tube are opened and inserted into hexane (10 min), polymer being taken out and washed by ethanol (24 hours), water (3 days), 1% solution of sodium hydroxide (1 day), and finally by water again (10 days, fresh water changed daily).
- the hydrogel is cut to 15 mm rolls that are freely dried in open air (2-3 days) and placed into a vial and closed. This method is carried out in a pure sterile room (max 100 particles in 1 m 3 ) under a germicide lamp.
- the resulting particles are 1.6 mm in diameter with a length of 4.5 mm.
- the hydrogel particles are mixed with wet DBM fibers in a 50/50 volume ratio and put into implant molds. The molds are put in a 40 degree C oven until dry and then removed and packaged. Upon hydration (after implantation), the hydrogel particles expand to 3.9 mm in diameter and 11 mm in length, causing the entire implant to expand.
- a cellulose sponge is rehydrated and cut into 4 mm cubes.
- the 4 mm cubes are mixed with wet DBM fibers in a 50/50 volume ration and put into implant molds.
- the molds are placed in a -70 degree C freezer until frozen, then placed in a lyophilizer until dried
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Transplantation (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Medicinal Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Vascular Medicine (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002594733A CA2594733A1 (en) | 2005-01-14 | 2006-01-17 | Expandable osteoimplant |
MX2007008561A MX2007008561A (en) | 2005-01-14 | 2006-01-17 | Expandable osteoimplant. |
AU2006204730A AU2006204730B2 (en) | 2005-01-14 | 2006-01-17 | Expandable osteoimplant |
ES06718593T ES2402056T3 (en) | 2005-01-14 | 2006-01-17 | Expandable Osteoimplant |
CN2006800082753A CN101141934B (en) | 2005-01-14 | 2006-01-17 | Expandable osteoimplant |
EP06718593A EP1838248B1 (en) | 2005-01-14 | 2006-01-17 | Expandable osteoimplant |
US11/776,070 US20080091270A1 (en) | 2005-01-14 | 2007-07-11 | Expandable osteoimplant |
AU2011200061A AU2011200061A1 (en) | 2005-01-14 | 2011-01-07 | Expandable osteoimplant |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64390105P | 2005-01-14 | 2005-01-14 | |
US60/643,901 | 2005-01-14 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/776,070 Continuation US20080091270A1 (en) | 2005-01-14 | 2007-07-11 | Expandable osteoimplant |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006076712A2 true WO2006076712A2 (en) | 2006-07-20 |
WO2006076712A3 WO2006076712A3 (en) | 2006-12-07 |
Family
ID=36168643
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/001540 WO2006076712A2 (en) | 2005-01-14 | 2006-01-17 | Expandable osteoimplant |
Country Status (8)
Country | Link |
---|---|
US (1) | US20080091270A1 (en) |
EP (1) | EP1838248B1 (en) |
CN (1) | CN101141934B (en) |
AU (2) | AU2006204730B2 (en) |
CA (1) | CA2594733A1 (en) |
ES (1) | ES2402056T3 (en) |
MX (1) | MX2007008561A (en) |
WO (1) | WO2006076712A2 (en) |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007056671A1 (en) * | 2005-11-02 | 2007-05-18 | Osteotech, Inc. | Hemostatic bone graft |
US7939108B2 (en) | 2000-12-14 | 2011-05-10 | Osteotech, Inc. | Method of making demineralized bone particles |
US7959941B2 (en) | 2001-10-12 | 2011-06-14 | Warsaw Orthopedic, Inc. | Bone graft comprising a demineralized bone matrix and a stabilizing agent |
US8002813B2 (en) | 1999-10-15 | 2011-08-23 | Warsaw Orthopedic, Inc. | Volume maintaining osteoinductive/osteoconductive compositions |
US8268008B2 (en) | 2003-06-11 | 2012-09-18 | Warsaw Orthopedic, Inc. | Osteoimplants and methods for their manufacture |
US8663672B2 (en) | 2000-07-19 | 2014-03-04 | Warsaw Orthopedic, Inc. | Osteoimplant and method of making same |
US8722075B2 (en) | 2008-10-24 | 2014-05-13 | Warsaw Orthopedic, Inc. | Compositions and methods for promoting bone formation |
US9132208B2 (en) | 2008-08-07 | 2015-09-15 | Lifenet Health | Composition for a tissue repair implant and methods of making the same |
US9408875B2 (en) | 2005-10-12 | 2016-08-09 | Lifenet Health | Compositions for repair of defects in tissues, and methods of making the same |
US9717822B2 (en) | 2007-06-15 | 2017-08-01 | Warsaw Orthopedic, Inc. | Bone matrix compositions and methods |
US9770339B2 (en) | 2005-07-14 | 2017-09-26 | Stout Medical Group, L.P. | Expandable support device and method of use |
EP3307336A4 (en) * | 2015-06-10 | 2018-06-20 | Globus Medical, Inc. | Biomaterial compositions, implants, and methods of making the same |
US10028837B2 (en) | 2007-07-10 | 2018-07-24 | Warsaw Orthopedic, Inc. | Delivery system attachment |
US10098681B2 (en) | 2009-02-12 | 2018-10-16 | Warsaw Orthopedic, Inc. | Segmented delivery system |
US10220115B2 (en) | 2007-06-15 | 2019-03-05 | Warsaw Orthopedic, Inc. | Bone matrix compositions having nanoscale textured surfaces |
US10285820B2 (en) | 2008-11-12 | 2019-05-14 | Stout Medical Group, L.P. | Fixation device and method |
USD849946S1 (en) | 2015-12-30 | 2019-05-28 | Nuvasive, Inc. | Interspinous process spacer |
US10328179B2 (en) | 2005-11-01 | 2019-06-25 | Warsaw Orthopedic, Inc. | Bone matrix compositions and methods |
US10531957B2 (en) | 2015-05-21 | 2020-01-14 | Musculoskeletal Transplant Foundation | Modified demineralized cortical bone fibers |
US10758289B2 (en) | 2006-05-01 | 2020-09-01 | Stout Medical Group, L.P. | Expandable support device and method of use |
US10940014B2 (en) | 2008-11-12 | 2021-03-09 | Stout Medical Group, L.P. | Fixation device and method |
US11051954B2 (en) | 2004-09-21 | 2021-07-06 | Stout Medical Group, L.P. | Expandable support device and method of use |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2550431A1 (en) | 2003-12-19 | 2005-07-14 | Osteotech, Inc. | Tissue-derived mesh for orthopedic regeneration |
US20070231788A1 (en) * | 2003-12-31 | 2007-10-04 | Keyvan Behnam | Method for In Vitro Assay of Demineralized Bone Matrix |
US8328876B2 (en) | 2003-12-31 | 2012-12-11 | Warsaw Orthopedic, Inc. | Bone matrix compositions and methods |
US8734525B2 (en) | 2003-12-31 | 2014-05-27 | Warsaw Orthopedic, Inc. | Osteoinductive demineralized cancellous bone |
WO2008157497A2 (en) * | 2007-06-15 | 2008-12-24 | Osteotech, Inc. | Method of treating tissue |
US20110054408A1 (en) * | 2007-07-10 | 2011-03-03 | Guobao Wei | Delivery systems, devices, tools, and methods of use |
US20100131069A1 (en) * | 2007-08-01 | 2010-05-27 | Jeffrey Halbrecht | Method and system for patella tendon realignment |
WO2009018365A1 (en) | 2007-08-01 | 2009-02-05 | Jeffrey Halbrecht | Method and system for patella tendon realignment |
WO2009052492A2 (en) * | 2007-10-19 | 2009-04-23 | Osteotech, Inc. | Demineralized bone matrix compositions and methods |
CN102046237A (en) * | 2008-03-28 | 2011-05-04 | 骨骼技术股份有限公司 | Delivery system attachment |
CA2741952C (en) * | 2008-11-06 | 2017-04-11 | Clil Medical Ltd. | Blood filtering device and method |
US20120135376A1 (en) * | 2009-03-30 | 2012-05-31 | Osseous Technologies Of America | Collagen Biomaterial Wedge |
US9668868B2 (en) | 2009-08-27 | 2017-06-06 | Cotera, Inc. | Apparatus and methods for treatment of patellofemoral conditions |
US9861408B2 (en) | 2009-08-27 | 2018-01-09 | The Foundry, Llc | Method and apparatus for treating canine cruciate ligament disease |
US10349980B2 (en) | 2009-08-27 | 2019-07-16 | The Foundry, Llc | Method and apparatus for altering biomechanics of the shoulder |
US9278004B2 (en) | 2009-08-27 | 2016-03-08 | Cotera, Inc. | Method and apparatus for altering biomechanics of the articular joints |
WO2011025959A1 (en) | 2009-08-27 | 2011-03-03 | The Foundry Llc | Method and apparatus for force redistributon in articular joints |
EP2547292B1 (en) | 2010-03-16 | 2019-04-24 | Pinnacle Spine Group, LLC | Ntervertebral implants and graft delivery systems |
US9352003B1 (en) | 2010-05-14 | 2016-05-31 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
US10130736B1 (en) | 2010-05-14 | 2018-11-20 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
US9149286B1 (en) | 2010-11-12 | 2015-10-06 | Flexmedex, LLC | Guidance tool and method for use |
CN102048601B (en) * | 2010-12-29 | 2013-04-17 | 哈尔滨医科大学 | Piston type titanium wire mesh cage and manufacturing method thereof |
JP2014529445A (en) | 2011-08-23 | 2014-11-13 | フレックスメデックス,エルエルシー | Tissue removal apparatus and method |
US9380932B1 (en) | 2011-11-02 | 2016-07-05 | Pinnacle Spine Group, Llc | Retractor devices for minimally invasive access to the spine |
CN103169551A (en) * | 2011-12-20 | 2013-06-26 | 财团法人金属工业研究发展中心 | Spine cage type support |
US9649427B2 (en) | 2011-12-28 | 2017-05-16 | Xerem Medical Ltd. | System and method for blood filtering and/or treatment |
US9283089B2 (en) * | 2012-04-05 | 2016-03-15 | Warsaw Orthopedic, Inc. | Interbody bone implant device |
US9730801B2 (en) * | 2012-04-17 | 2017-08-15 | Warsaw Orthopedic, Inc. | Interbody bone implant device |
US10207027B2 (en) | 2012-06-11 | 2019-02-19 | Globus Medical, Inc. | Bioactive bone graft substitutes |
US9468466B1 (en) | 2012-08-24 | 2016-10-18 | Cotera, Inc. | Method and apparatus for altering biomechanics of the spine |
US9034052B2 (en) * | 2013-01-14 | 2015-05-19 | Warsaw Orthopedic, Inc. | Delivery systems containing bioactive materials |
WO2014159739A1 (en) | 2013-03-14 | 2014-10-02 | Pinnacle Spine Group, Llc | Interbody implants and graft delivery systems |
US9539286B2 (en) | 2013-10-18 | 2017-01-10 | Globus Medical, Inc. | Bone grafts including osteogenic stem cells, and methods relating to the same |
US9486483B2 (en) | 2013-10-18 | 2016-11-08 | Globus Medical, Inc. | Bone grafts including osteogenic stem cells, and methods relating to the same |
US9579421B2 (en) | 2014-02-07 | 2017-02-28 | Globus Medical Inc. | Bone grafts and methods of making and using bone grafts |
US9463264B2 (en) | 2014-02-11 | 2016-10-11 | Globus Medical, Inc. | Bone grafts and methods of making and using bone grafts |
US10173375B2 (en) | 2014-03-05 | 2019-01-08 | Bacterin International, Inc. | Shaped fiber-based products and method of manufacture thereof |
US10016529B2 (en) | 2015-06-10 | 2018-07-10 | Globus Medical, Inc. | Biomaterial compositions, implants, and methods of making the same |
US9839524B2 (en) * | 2015-06-22 | 2017-12-12 | Theodore Malinin | Modified, pliable, and compressible cortical bone for spinal fusions and other skeletal transplants |
US10821004B2 (en) * | 2015-06-30 | 2020-11-03 | Bacterin Interational, Inc. | Expandable bone grafts and methods of manufacture thereof |
US20170056201A1 (en) * | 2015-08-26 | 2017-03-02 | Wiltrom Co., Ltd. | Intervertebral fusion apparatus for positioning and combining vertebrae |
US10549011B2 (en) | 2015-10-26 | 2020-02-04 | Osteolife Biomedical, Llc | Bone putty and gel systems and methods |
US20170128633A1 (en) | 2015-11-10 | 2017-05-11 | Theodore Malinin | Bioactive Implants and Methods of Making and Using |
WO2018013595A1 (en) * | 2016-07-11 | 2018-01-18 | Theracell, Inc. | Bone derived fibers and oxygenated wound treatments |
WO2018071053A1 (en) * | 2016-10-14 | 2018-04-19 | Allosource | Consistent calcium content bone allograft systems and methods |
GB201708909D0 (en) * | 2017-06-05 | 2017-07-19 | Orthox Ltd | Implantable tissue repair devices and methods for manufacturing the same |
KR102632931B1 (en) * | 2017-06-30 | 2024-02-05 | 알로소스 | Cellular bone grafts and methods of manufacture and use |
US11896476B2 (en) | 2020-01-02 | 2024-02-13 | Zkr Orthopedics, Inc. | Patella tendon realignment implant with changeable shape |
US11896736B2 (en) | 2020-07-13 | 2024-02-13 | Globus Medical, Inc | Biomaterial implants and methods of making the same |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998017209A2 (en) | 1996-10-23 | 1998-04-30 | Sdgi Holdings, Inc. | Spinal spacer |
WO2000035510A1 (en) | 1998-12-14 | 2000-06-22 | Osteotech, Inc. | Bone graft and guided bone regeneration method |
US20020120338A1 (en) | 2001-02-28 | 2002-08-29 | Boyer Michael L. | Implants formed with demineralized bone |
Family Cites Families (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US159334A (en) * | 1875-02-02 | Improvement in machines for crushing bones | ||
US3947287A (en) * | 1971-11-15 | 1976-03-30 | Badische Anilin- & Soda-Fabrik Aktiengesellschaft | Aqueous pigment dispersions |
US4134792A (en) * | 1976-12-06 | 1979-01-16 | Miles Laboratories, Inc. | Specific binding assay with an enzyme modulator as a labeling substance |
US4363319A (en) * | 1980-06-30 | 1982-12-14 | Applied Medical Devices, Inc. | Ready-to-use bandage incorporating a coagulant composition and method of preparing same |
US4795463A (en) * | 1984-10-03 | 1989-01-03 | Baylor College Of Medicine | Labeled breast prosthesis and methods for detecting and predicting rupture of the prosthesis |
US4709703A (en) * | 1985-11-12 | 1987-12-01 | Mayo Foundation | Imaging system and method using radiopaque microspheres for evaluation of organ tissue perfusion |
US5139527A (en) * | 1987-12-17 | 1992-08-18 | Immuno Aktiengesellschaft | Biologic absorbable implant material for filling and closing soft tissue cavities and method of its preparation |
DE3831657A1 (en) * | 1988-09-17 | 1990-03-22 | Boehringer Ingelheim Kg | DEVICE FOR THE OSTEOSYNTHESIS AND METHOD FOR THE PRODUCTION THEREOF |
US5432000A (en) * | 1989-03-20 | 1995-07-11 | Weyerhaeuser Company | Binder coated discontinuous fibers with adhered particulate materials |
US5290558A (en) * | 1989-09-21 | 1994-03-01 | Osteotech, Inc. | Flowable demineralized bone powder composition and its use in bone repair |
US5723117A (en) * | 1990-08-10 | 1998-03-03 | Otsuka Pharmaceutical Co., Ltd. | Use of interleukin-1 (IL-1) to inhibit development of hepatitis |
US5171278A (en) * | 1991-02-22 | 1992-12-15 | Madhavan Pisharodi | Middle expandable intervertebral disk implants |
US6503277B2 (en) * | 1991-08-12 | 2003-01-07 | Peter M. Bonutti | Method of transplanting human body tissue |
US5329846A (en) * | 1991-08-12 | 1994-07-19 | Bonutti Peter M | Tissue press and system |
US5282827A (en) * | 1991-11-08 | 1994-02-01 | Kensey Nash Corporation | Hemostatic puncture closure system and method of use |
US5314476A (en) * | 1992-02-04 | 1994-05-24 | Osteotech, Inc. | Demineralized bone particles and flowable osteogenic composition containing same |
US5366507A (en) * | 1992-03-06 | 1994-11-22 | Sottosanti John S | Method for use in bone tissue regeneration |
US5334216A (en) * | 1992-12-10 | 1994-08-02 | Howmedica Inc. | Hemostatic plug |
US5507813A (en) * | 1993-12-09 | 1996-04-16 | Osteotech, Inc. | Shaped materials derived from elongate bone particles |
US5496375A (en) * | 1994-09-14 | 1996-03-05 | Zimmer, Inc. | Prosthetic implant with circumferential porous pad having interlocking tabs |
US6599515B1 (en) * | 1995-01-16 | 2003-07-29 | Baxter International Inc. | Fibrin porous structure |
US5676146B1 (en) * | 1996-09-13 | 2000-04-18 | Osteotech Inc | Surgical implant containing a resorbable radiopaque marker and method of locating such within a body |
US20020137890A1 (en) * | 1997-03-31 | 2002-09-26 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US6652592B1 (en) * | 1997-10-27 | 2003-11-25 | Regeneration Technologies, Inc. | Segmentally demineralized bone implant |
US7087082B2 (en) * | 1998-08-03 | 2006-08-08 | Synthes (Usa) | Bone implants with central chambers |
US6123731A (en) * | 1998-02-06 | 2000-09-26 | Osteotech, Inc. | Osteoimplant and method for its manufacture |
US7045141B2 (en) * | 1998-02-27 | 2006-05-16 | Musculoskeletal Transplant Foundation | Allograft bone composition having a gelatin binder |
US6030635A (en) * | 1998-02-27 | 2000-02-29 | Musculoskeletal Transplant Foundation | Malleable paste for filling bone defects |
US6224630B1 (en) * | 1998-05-29 | 2001-05-01 | Advanced Bio Surfaces, Inc. | Implantable tissue repair device |
WO2000007639A1 (en) * | 1998-08-07 | 2000-02-17 | Tissue Engineering, Inc. | Bone precursor compositions |
US6206923B1 (en) * | 1999-01-08 | 2001-03-27 | Sdgi Holdings, Inc. | Flexible implant using partially demineralized bone |
WO2000045753A1 (en) * | 1999-02-04 | 2000-08-10 | Sdgi Holdings, Inc. | Improved interbody fusion device with anti-rotation features |
US6294187B1 (en) * | 1999-02-23 | 2001-09-25 | Osteotech, Inc. | Load-bearing osteoimplant, method for its manufacture and method of repairing bone using same |
US6696073B2 (en) * | 1999-02-23 | 2004-02-24 | Osteotech, Inc. | Shaped load-bearing osteoimplant and methods of making same |
US6375663B1 (en) * | 1999-03-17 | 2002-04-23 | Maxilon Laboratories, Inc. | Bone grafting material |
EP1194086A4 (en) * | 1999-06-08 | 2003-03-19 | Osteotech Inc | Keyed intervertebral dowel |
US20030228288A1 (en) * | 1999-10-15 | 2003-12-11 | Scarborough Nelson L. | Volume maintaining osteoinductive/osteoconductive compositions |
US6630153B2 (en) * | 2001-02-23 | 2003-10-07 | Smith & Nephew, Inc. | Manufacture of bone graft substitutes |
EP1296726B1 (en) * | 2000-07-03 | 2004-02-04 | Osteotech, Inc. | Osteogenic implants derived from bone |
US6863694B1 (en) * | 2000-07-03 | 2005-03-08 | Osteotech, Inc. | Osteogenic implants derived from bone |
US9387094B2 (en) * | 2000-07-19 | 2016-07-12 | Warsaw Orthopedic, Inc. | Osteoimplant and method of making same |
US20020026244A1 (en) * | 2000-08-30 | 2002-02-28 | Trieu Hai H. | Intervertebral disc nucleus implants and methods |
EP1331906A2 (en) * | 2000-10-25 | 2003-08-06 | SDGI Holdings, Inc. | Vertically expanding intervertebral body fusion device |
AU2002225831A1 (en) * | 2000-11-03 | 2002-05-15 | Osteotech, Inc. | Spinal intervertebral implant and method of making |
US7323193B2 (en) * | 2001-12-14 | 2008-01-29 | Osteotech, Inc. | Method of making demineralized bone particles |
US6723131B2 (en) * | 2001-02-28 | 2004-04-20 | The Cleveland Clinic Foundation | Composite bone marrow graft material with method and kit |
US6595998B2 (en) * | 2001-03-08 | 2003-07-22 | Spinewave, Inc. | Tissue distraction device |
KR20040047746A (en) * | 2001-10-12 | 2004-06-05 | 오스테오테크, 인코포레이티드 | Improved bone graft |
US6733534B2 (en) * | 2002-01-29 | 2004-05-11 | Sdgi Holdings, Inc. | System and method for spine spacing |
WO2003079985A2 (en) * | 2002-03-18 | 2003-10-02 | Carnegie Mellon University | Method and apparatus for preparing biomimetic scaffold |
RU2341296C2 (en) * | 2002-05-24 | 2008-12-20 | Энджиотек Интернэшнл Аг | Compositions and methods of medical implant covering |
US7582309B2 (en) * | 2002-11-15 | 2009-09-01 | Etex Corporation | Cohesive demineralized bone compositions |
US7507257B2 (en) * | 2003-02-04 | 2009-03-24 | Wright Medical Technology, Inc. | Injectable resorbable bone graft material, powder for forming same and methods relating thereto for treating bone defects |
US7252685B2 (en) * | 2003-06-05 | 2007-08-07 | Sdgi Holdings, Inc. | Fusion implant and method of making same |
-
2006
- 2006-01-17 CN CN2006800082753A patent/CN101141934B/en not_active Expired - Fee Related
- 2006-01-17 CA CA002594733A patent/CA2594733A1/en not_active Abandoned
- 2006-01-17 AU AU2006204730A patent/AU2006204730B2/en not_active Ceased
- 2006-01-17 ES ES06718593T patent/ES2402056T3/en active Active
- 2006-01-17 EP EP06718593A patent/EP1838248B1/en not_active Not-in-force
- 2006-01-17 WO PCT/US2006/001540 patent/WO2006076712A2/en active Application Filing
- 2006-01-17 MX MX2007008561A patent/MX2007008561A/en active IP Right Grant
-
2007
- 2007-07-11 US US11/776,070 patent/US20080091270A1/en not_active Abandoned
-
2011
- 2011-01-07 AU AU2011200061A patent/AU2011200061A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998017209A2 (en) | 1996-10-23 | 1998-04-30 | Sdgi Holdings, Inc. | Spinal spacer |
WO2000035510A1 (en) | 1998-12-14 | 2000-06-22 | Osteotech, Inc. | Bone graft and guided bone regeneration method |
US20020120338A1 (en) | 2001-02-28 | 2002-08-29 | Boyer Michael L. | Implants formed with demineralized bone |
Cited By (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8002813B2 (en) | 1999-10-15 | 2011-08-23 | Warsaw Orthopedic, Inc. | Volume maintaining osteoinductive/osteoconductive compositions |
US8197474B2 (en) | 1999-10-15 | 2012-06-12 | Warsaw Orthopedic, Inc. | Volume maintaining osteoinductive/osteoconductive compositions |
US8663672B2 (en) | 2000-07-19 | 2014-03-04 | Warsaw Orthopedic, Inc. | Osteoimplant and method of making same |
US9999520B2 (en) | 2000-07-19 | 2018-06-19 | Warsaw Orthopedic, Inc. | Osteoimplant and method of making same |
US9387094B2 (en) | 2000-07-19 | 2016-07-12 | Warsaw Orthopedic, Inc. | Osteoimplant and method of making same |
US8529962B2 (en) | 2000-12-14 | 2013-09-10 | Warsaw Orthopedic, Inc. | Method of making demineralized bone particles |
US7939108B2 (en) | 2000-12-14 | 2011-05-10 | Osteotech, Inc. | Method of making demineralized bone particles |
US7959941B2 (en) | 2001-10-12 | 2011-06-14 | Warsaw Orthopedic, Inc. | Bone graft comprising a demineralized bone matrix and a stabilizing agent |
US8753689B2 (en) | 2001-12-14 | 2014-06-17 | Warsaw Orthopedic, Inc. | Method of making demineralized bone particles |
US9393116B2 (en) | 2003-06-11 | 2016-07-19 | Warsaw Orthopedic, Inc. | Osteoimplants and methods for their manufacture |
US8268008B2 (en) | 2003-06-11 | 2012-09-18 | Warsaw Orthopedic, Inc. | Osteoimplants and methods for their manufacture |
US11051954B2 (en) | 2004-09-21 | 2021-07-06 | Stout Medical Group, L.P. | Expandable support device and method of use |
US9770339B2 (en) | 2005-07-14 | 2017-09-26 | Stout Medical Group, L.P. | Expandable support device and method of use |
US9408875B2 (en) | 2005-10-12 | 2016-08-09 | Lifenet Health | Compositions for repair of defects in tissues, and methods of making the same |
US10328179B2 (en) | 2005-11-01 | 2019-06-25 | Warsaw Orthopedic, Inc. | Bone matrix compositions and methods |
WO2007056671A1 (en) * | 2005-11-02 | 2007-05-18 | Osteotech, Inc. | Hemostatic bone graft |
US8545864B2 (en) | 2005-11-02 | 2013-10-01 | Warsaw Orthopedic, Inc. | Hemostatic bone graft |
US11141208B2 (en) | 2006-05-01 | 2021-10-12 | Stout Medical Group, L.P. | Expandable support device and method of use |
US10813677B2 (en) | 2006-05-01 | 2020-10-27 | Stout Medical Group, L.P. | Expandable support device and method of use |
US10758289B2 (en) | 2006-05-01 | 2020-09-01 | Stout Medical Group, L.P. | Expandable support device and method of use |
US9717822B2 (en) | 2007-06-15 | 2017-08-01 | Warsaw Orthopedic, Inc. | Bone matrix compositions and methods |
US10220115B2 (en) | 2007-06-15 | 2019-03-05 | Warsaw Orthopedic, Inc. | Bone matrix compositions having nanoscale textured surfaces |
US10357511B2 (en) | 2007-06-15 | 2019-07-23 | Warsaw Orthopedic, Inc. | Bone matrix compositions and methods |
US10028837B2 (en) | 2007-07-10 | 2018-07-24 | Warsaw Orthopedic, Inc. | Delivery system attachment |
US9132208B2 (en) | 2008-08-07 | 2015-09-15 | Lifenet Health | Composition for a tissue repair implant and methods of making the same |
US8722075B2 (en) | 2008-10-24 | 2014-05-13 | Warsaw Orthopedic, Inc. | Compositions and methods for promoting bone formation |
US10292828B2 (en) | 2008-11-12 | 2019-05-21 | Stout Medical Group, L.P. | Fixation device and method |
US10285819B2 (en) | 2008-11-12 | 2019-05-14 | Stout Medical Group, L.P. | Fixation device and method |
US10285820B2 (en) | 2008-11-12 | 2019-05-14 | Stout Medical Group, L.P. | Fixation device and method |
US10940014B2 (en) | 2008-11-12 | 2021-03-09 | Stout Medical Group, L.P. | Fixation device and method |
US10098681B2 (en) | 2009-02-12 | 2018-10-16 | Warsaw Orthopedic, Inc. | Segmented delivery system |
US10531957B2 (en) | 2015-05-21 | 2020-01-14 | Musculoskeletal Transplant Foundation | Modified demineralized cortical bone fibers |
US11596517B2 (en) | 2015-05-21 | 2023-03-07 | Musculoskeletal Transplant Foundation | Modified demineralized cortical bone fibers |
EP3307336A4 (en) * | 2015-06-10 | 2018-06-20 | Globus Medical, Inc. | Biomaterial compositions, implants, and methods of making the same |
US11426489B2 (en) | 2015-06-10 | 2022-08-30 | Globus Medical, Inc. | Biomaterial compositions, implants, and methods of making the same |
USD849946S1 (en) | 2015-12-30 | 2019-05-28 | Nuvasive, Inc. | Interspinous process spacer |
Also Published As
Publication number | Publication date |
---|---|
WO2006076712A3 (en) | 2006-12-07 |
AU2006204730B2 (en) | 2011-03-31 |
CA2594733A1 (en) | 2006-07-20 |
EP1838248B1 (en) | 2013-03-06 |
ES2402056T3 (en) | 2013-04-26 |
CN101141934A (en) | 2008-03-12 |
US20080091270A1 (en) | 2008-04-17 |
AU2011200061A1 (en) | 2011-01-27 |
MX2007008561A (en) | 2008-02-21 |
CN101141934B (en) | 2010-11-24 |
AU2006204730A1 (en) | 2006-07-20 |
EP1838248A2 (en) | 2007-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2006204730B2 (en) | Expandable osteoimplant | |
ES2260783T3 (en) | PROCEDURE TO PRODUCE FLEXIBLE SHEETS FROM LONG AND DEMINERALIZED OSE PARTICLES. | |
JP4851513B2 (en) | Synthetic collagen-mineral complex for load support useful for spinal implant and method for producing the same | |
US6432436B1 (en) | Partially demineralized cortical bone constructs | |
US20060204544A1 (en) | Allograft bone composition having a gelatin binder | |
WO1995015776A1 (en) | Shaped materials derived from elongate bone particles and process for making same | |
US11622865B2 (en) | Expandable bone grafts and methods of manufacture thereof | |
US11896736B2 (en) | Biomaterial implants and methods of making the same | |
US20120205274A1 (en) | Allograft bone composition having a gelatin binder | |
US11426489B2 (en) | Biomaterial compositions, implants, and methods of making the same | |
AU2013205656A1 (en) | Expandable osteoimplant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200680008275.3 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2006204730 Country of ref document: AU |
|
ENP | Entry into the national phase in: |
Ref document number: 2594733 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11776070 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/a/2007/008561 Country of ref document: MX |
|
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006718593 Country of ref document: EP |
|
ENP | Entry into the national phase in: |
Ref document number: 2006204730 Country of ref document: AU Date of ref document: 20060117 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 07081510 Country of ref document: CO |
|
WWE | Wipo information: entry into national phase |
Ref document number: 6315/DELNP/2007 Country of ref document: IN |